bpi_logo_whiteMission Statement: The mission of Phoenicia is to advance development of therapeutics for treatment of blood diseases and cancer, with a focus on global medical needs lacking satisfactory therapies.

About Phoenicia: Phoenicia is a Boston-based biopharmaceutical company developing proprietary small molecules which target specific genes for the treatment of serious hematologic disorders, cancer and chronic wounds. Lead clinical drug candidates are for sickle cell disease and β-thalassemia, viral-associated and ras-mutated cancers, deficiencies of blood production, and chronic wounds. The Company has been supported by federal small business grants.

Phoenicia provides consulting to academic investigators and early biotechnology businesses to enable new INDs.